z-logo
open-access-imgOpen Access
Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306
Author(s) -
Oluwatosin Goje,
Ryan Sobel,
Paul Nyirjesy,
Steven R. Goldstein,
Mark Spitzer,
Brooke Faught,
Shelagh Larson,
Thomas King,
Nkechi Azie,
David Angulo,
Jack D. Sobel
Publication year - 2022
Publication title -
journal of women s health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.195
H-Index - 98
eISSN - 1931-843X
pISSN - 1540-9996
DOI - 10.1089/jwh.2022.0132
Subject(s) - vulvovaginal candidiasis , medicine , dermatology , gynecology , antifungal

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom